SCHEMBL18708458

SCHEMBL18708458

O=C(O)c1cccc(-c2nnc(-c3ccc4c(c3)OCC4)o2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MYC P01106 1/20 0.51
▸ FABP4 P15090 1/20 0.51
▸ NPC1 O15118 6/20 0.50
▸ RAB9A P51151 6/20 0.50
▸ KMT2A Q03164 4/20 0.50
▸ STIM1 Q13586 2/20 0.49
▸ ORAI1 Q96D31 2/20 0.49
▸ ADCY1 Q08828 4/20 0.48
▸ PRKAB2 O43741 1/20 0.47
▸ PRKAG1 P54619 1/20 0.47
▸ PRKAA2 P54646 1/20 0.47
▸ PRKAA1 Q13131 1/20 0.47
▸ PRKAG3 Q9UGI9 1/20 0.47
▸ PRKAG2 Q9UGJ0 1/20 0.47
▸ PRKAB1 Q9Y478 1/20 0.47
▸ SMN1; SMN2 Q16637 5/20 0.46
▸ ALDH1A1 P00352 4/20 0.46
▸ HPGD P15428 3/20 0.46
▸ MEN1 O00255 3/20 0.46
▸ MAPK1 P28482 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12871205 0.86 STIM1 (0.64) MYCNPC1RAB9AKMT2ASTIM1
SCHEMBL11579267 0.81 NPC1 (0.66) MYCNPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL12798177 0.81 NPC1 (0.60) MYCNPC1RAB9AKMT2ASTIM1
SCHEMBL12171364 0.79 NPC1 (0.73) MYCNPC1RAB9AKMT2AADCY1
SCHEMBL4395868 0.78 NPC1 (0.72) MYCNPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL18708511 0.77 MYC (0.50) MYCNPC1RAB9AKMT2AADCY1
SCHEMBL10483674 0.76 MYC (0.67) MYCNPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL2242305 0.76 PRKAB2 (0.50) FABP4PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL4685014 0.75 ALDH1A1 (0.55) FABP4NPC1RAB9APRKAB2PRKAG1
SCHEMBL12171784 0.75 NPC1 (0.62) MYCNPC1RAB9AKMT2AADCY1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9611230-B2 1,3,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease PTC THERAPEUTICS, INC. (US) 2017-04-04 — — US disclosed
Send feedback